Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Bristol-Myers Squibb begins phase II testing of inlicensed quinolone

Nov. 12, 1999

New data reported for Tamiflu as influenza treatment and prophylaxis

Nov. 10, 1999

Inhibitex enters collaboration with ZLB for S. aureus antiinfective agents

Nov. 8, 1999

Potential interaction between S-4661 and valproic acid

Nov. 8, 1999

Antiviral agents discovered at U. of Michigan

Nov. 8, 1999

Glaxo Wellcome files for approval of new Relenza indications: influenza prophylaxis, pediatric use

Nov. 8, 1999

Large clinical trial to evaluate AG-7088 nasal spray as a common cold remedy commences

Nov. 5, 1999

Novel inhibitors of multidrug transporter mediating fluoroquinolone efflux

Nov. 5, 1999

Breakthrough flu treatment approved by Health Canada

Nov. 5, 1999

Glaxo Wellcome to market Crystacide in Latin America, Caribbean

Nov. 5, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...